The problem with Europe’s much discussed fragmented life sciences market, in contrast with US hubs like Boston, is perhaps most acute at the earliest stage. The continent’s abundance of scientists can struggle to find the resources to develop their hypotheses to the point where venture capital comes into play.
The Copenhagen, Denmark-based BioInnovation Institute (BII) aims to fill this crucial gap in the life sciences journey. This comes down...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?